Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability
about
Beyond empiricism: informing vaccine development through innate immunity researchSystematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsComparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza.Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.An update on the use of laser technology in skin vaccination.Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response.Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and componentsChitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model.Synthetic adjuvants for vaccine formulations: phytol derivatives.Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications.Physicochemical and functional characterization of vaccine antigens and adjuvants.Particulate inorganic adjuvants: recent developments and future outlook.Adjuvants in micro- to nanoscale: current state and future direction.Clinical use of adjuvants in allergen-immunotherapy.Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.Mechanism of immunopotentiation and safety of aluminum adjuvants.Dietary L-proline supplementation confers immunostimulatory effects on inactivated Pasteurella multocida vaccine immunized mice.Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures.Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality.On-farm storage of livestock vaccines may be a risk to vaccine efficacy: a study of the performance of on-farm refrigerators to maintain the correct storage temperature.Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
P2860
Q26824573-F7CB652C-42BB-43C5-A619-B5524C3E3177Q28387541-91104362-2174-45F3-BADF-6487F82489A1Q30400393-CA69326D-5926-488A-A8F6-95BBA300ED28Q34344419-28766116-74DA-4B26-86C7-1D14655FD8CCQ34455041-F39C613C-9E7D-4097-B227-739BB543B853Q35017651-7387FB90-6B49-43F3-B7AA-F7B126798AD9Q35181390-70EC894C-D967-4946-BBD3-11C028DC8DFCQ35318199-C1ED5AC8-4CBE-402C-B29E-7DC2FF593662Q36090625-82BA7A3F-8346-4BF0-9469-A8876802E500Q37132243-6F7F16A3-0290-4A35-8BA5-CB7FEA22CEFEQ38072067-6E3E02ED-24A0-452E-89B5-FD5AC7B5A4E5Q38113269-8C9CAE8E-B27E-4F76-8C22-E751F96B896DQ38202170-44488732-B2BC-4C78-816D-B872335A3D15Q38286377-2A4E092D-7EC8-4379-842A-AACD38964D93Q38520210-678F86E8-1E45-4614-AADD-6A443A2A39D7Q38761412-322F3CCF-4C11-4FAC-A9B5-F1EC7D54F40BQ40438006-1522FFD2-21A8-4AC7-AAF2-335F324BD670Q41931571-19A8E10B-8871-42A9-B585-29D94EBEE4A4Q42036323-1A0F99AE-5506-4F88-A776-A056563F04ABQ43507253-29E62F8C-956F-4A30-B0F2-E0A0C0D486D0Q50027680-A15F69BF-6814-4BD2-AD0D-C6B45592F8D1Q50060583-F5680095-DD2C-4D57-84AD-5A820977A1EAQ50113262-7D82DD6D-9C08-4A32-8873-2BE936927787Q54968840-269598A8-C7CC-4432-AE8F-5226EF5E3200Q59137099-CA6041C0-0A2F-4358-8306-1FBF96C69D90
P2860
Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vaccines with aluminum-contain ...... efficacy and thermal stability
@ast
Vaccines with aluminum-contain ...... efficacy and thermal stability
@en
Vaccines with aluminum-contain ...... efficacy and thermal stability
@nl
type
label
Vaccines with aluminum-contain ...... efficacy and thermal stability
@ast
Vaccines with aluminum-contain ...... efficacy and thermal stability
@en
Vaccines with aluminum-contain ...... efficacy and thermal stability
@nl
prefLabel
Vaccines with aluminum-contain ...... efficacy and thermal stability
@ast
Vaccines with aluminum-contain ...... efficacy and thermal stability
@en
Vaccines with aluminum-contain ...... efficacy and thermal stability
@nl
P2093
P2860
P3181
P356
P1476
Vaccines with aluminum-contain ...... efficacy and thermal stability
@en
P2093
Dexiang Chen
LaToya Jones Braun
Paul Siebert
Tanya Clapp
P2860
P304
P3181
P356
10.1002/JPS.22284
P407
P577
2011-02-01T00:00:00Z